Primo Chemicals
22.28
+0.41(+1.87%)
Market Cap₹539.94 Cr
PE Ratio52.14
IndustryChemicals
Company Performance:
1D+1.87%
1M-6.35%
6M-19.25%
1Y-20.31%
5Y-20.31%
View Company Insightsright
More news about Primo Chemicals
24Oct 25
Primo Chemicals' Independent Director Teesta Sandhu Steps Down
Ms. Teesta Sandhu has resigned from her position as Independent Director at Primo Chemicals Limited, effective October 23, 2025, citing personal and professional commitments. She will also step down from her role in the Risk Management Committee. The company has disclosed this information in compliance with SEBI regulations.
 no imag found
14Aug 25
Primo Chemicals Reports Q1 Profit, Approves Key Appointments and Acquisition
Primo Chemicals Limited announced Q1 FY2025-26 results with a net profit of Rs 407.76 crore, up from a loss of Rs 1,124.97 crore in Q1 FY2024-25. Revenue increased to Rs 1,419.38 crore. The board approved appointing M/s. A. Arora & Co. as Secretarial Auditor, re-appointing three Independent Directors, and acquiring the remaining 51% stake in Flow Tech Chemicals. The 50th AGM is scheduled for September 30, 2025.
 no imag found
23Jul 25
Primo Chemicals' Credit Ratings Reaffirmed by CARE, Outlook Revised to Stable
CARE Ratings has reaffirmed Primo Chemicals Limited's (PCL) credit ratings while upgrading its outlook from negative to stable. The long-term bank facilities rating of CARE BBB- was reaffirmed for Rs. 102.71 crore, reduced from Rs. 133.27 crore. The long-term/short-term bank facilities rating of CARE BBB-/CARE A3 was maintained for Rs. 75.00 crore. This improved outlook suggests enhanced financial stability and may lead to better credibility, borrowing terms, and investor confidence for PCL.
 no imag found
23Jul 25
CARE Ratings Upgrades Outlook for Primo Chemicals' Credit Ratings to Stable
CARE Ratings has reaffirmed Primo Chemicals Limited's credit ratings while upgrading the outlook from negative to stable. The long-term bank facilities rating of CARE BBB- was reaffirmed for Rs. 102.71 crore, reduced from Rs. 133.27 crore. The long-term/short-term bank facilities rating of CARE BBB-/CARE A3 was maintained for Rs. 75.00 crore. This improved outlook suggests enhanced financial stability and could potentially boost the company's credibility, borrowing capacity, and market confidence.
 no imag found
30May 25
Primo Chemicals Reports Mixed Q4 Results: Revenue Surges, but Profits Decline
Primo Chemicals announced its Q4 financial results, showing a 51.5% year-over-year revenue increase to ₹1.56 billion. However, the company reported a net loss of ₹11.20 million, down from a ₹68.00 million profit in the same quarter last year and a ₹19.20 million profit in the previous quarter. The contrasting trends indicate strong product demand but significant challenges in maintaining profitability, possibly due to increased costs or competitive pressures in the chemical industry.
 no imag found
Primo Chemicals
22.28
+0.41
(+1.87%)
1 Year Returns:-20.31%
Industry Peers